Hyperthermic Yoga for Depressive Symptoms



Status:Recruiting
Conditions:Depression, Depression, Major Depression Disorder (MDD), Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 60
Updated:1/13/2019
Start Date:February 20, 2017
End Date:March 31, 2021
Contact:Maren Nyer, PhD
Email:mnyer@partners.org
Phone:617-643-4897

Use our guide to learn which trials are right for you!

Mechanisms of Hyperthermic Yoga for the Treatment of Depression

Study is a randomized controlled trial to assess the feasibility, acceptability, efficacy,
and mechanisms of action of hyperthermic yoga versus a waitlist control for 80 medically
healthy adults with mild to moderate depressive symptoms. The primary aim is to test the
acceptability and feasibility of hyperthermic yoga as a treatment for depression. The
secondary aim is to examine the effect size/efficacy of hyperthermic yoga for depressive
symptoms. The tertiary aim is to explore physiological and psychological mechanisms of
action.


Inclusion Criteria

1. Adults ages 18-60

2. English language proficiency

3. Ability to provide informed consent

4. Score of >23 on the Inventory of Depressive Symptomatology - Clinician Rated (IDS-CR)

5. Able and willing to attend two 90-minute hyperthermic yoga sessions per week

6. Willingness to keep existing exercise regimen (even if that is sedentary) stable over
study course

7. Women of childbearing potential must use an acceptable form of birth control

8. Membership to the Bikram Yoga Boston and Bikram Yoga Cambridge studios via studio
website "Interested in research" option through a centralized portal (this will remain
central until January 1, 2017)

9. Willingness to adhere to hydration requirements (i.e., an additional four 8 oz
servings of water pre- and post-yoga classes)

Exclusion Criteria

1. Pregnancy or planned pregnancy during study

2. History of psychiatric hospitalization within the past year

3. Active suicidal intent within the past year ("yes" on item 4 or 5 on the
Columbia-Suicide Severity Rating Scale)

4. History of neurologic disorders that could interfere in study participation

5. History of bipolar disorder, psychotic disorders, eating disorders, and/or substance
abuse or dependence (within the last year), as per the Mini-International
Neuropsychiatric Interview (MINI)

6. Psychotropic medication use that has been stable for <3 months

7. Use of stimulant medications or diet pills during the study, or any pre-workout
powders or liquids designed to provide excessive energy

8. Positive urine toxicology screen due to illicit drug use or other exclusionary
medications. (Potential false positives will be addressed on a case-by-case basis at
the discretion of the investigator)

9. Active conditions which may also cause depressive symptoms (e.g. epilepsy,
hypothyroidism)

10. Medical conditions that may make participation unsafe (e.g., diabetes [I & II],
cardiovascular disease, hypertension [>140 systolic and/or >90 diastolic], hypotension
[<90 systolic and/or <60 diastolic, during screening], orthostatic hypotension
[systolic drop of 20 points or 10 point diastolic or heart rate increase by 10],
autoimmune disorders, malignancy, or autonomic dysfunction)

11. > 6 one hour classes of meditation or other mind-body disciplines (e.g., Tai chi or
yoga) within the last 6 months

12. Current individual or group psychotherapy established for <3 months

13. A subject who in the opinion of the Principal Investigator would not be able to safely
complete the study or would jeopardize study integrity

14. History of heat intolerance or heat stroke

15. Unsafe cardiac status as defined by abnormal ECG reading at screening visit as
determined by medical monitor, study doctor, or subject's PCP or cardiologist
We found this trial at
1
site
Boston, Massachusetts 02114
Principal Investigator: Maren Nyer, PhD
Phone: 617-643-4897
?
mi
from
Boston, MA
Click here to add this to my saved trials